 |
인쇄하기
취소
|
Hanmi launches chemically modified Nexium
Hanmi Pharm says it has launched a chemically modified Nexium (S-omeprazole magnesium), Esomezole (esomeprazole strontium), in the domestic market.
Esomeprazole is a proton pump inhibitor developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome.
Strontium is the active ing...
Esomeprazole is a proton pump inhibitor developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome.
Strontium is the active ing...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.